Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v6-FR | Version v1-EN | |
---|---|---|
Language | French | English |
Date Updated | 2024-12-10 | 2023-08-15 |
Drug Identification Number | 00299979 | 00299979 |
Brand name | ALLERGENIC EXTRACT NON POLLENS | ALLERGENIC EXTRACT NON POLLENS |
Common or Proper name | Peanut | Peanut |
Company Name | ALK-ABELLO INC | ALK-ABELLO INC |
Ingredients | NON POLLEN | NON POLLEN |
Strength(s) | 100000UNIT | 100000UNIT |
Dosage form(s) | LIQUID | LIQUID |
Route of administration | PERCUTANEOUS SUBCUTANEOUS INTRADERMAL PERCUTANEOUS SUBCUTANEOUS INTRADERMAL | PERCUTANEOUS SUBCUTANEOUS INTRADERMAL PERCUTANEOUS SUBCUTANEOUS INTRADERMAL |
Packaging sizes (GTIN) | (See additional packaging sizes) | (See additional packaging sizes) |
Additional packaging sizes | 5mL, 10mL | 5mL, 10mL |
ATC code | V01AA | V01AA |
ATC description | ALLERGENS | ALLERGENS |
Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
Anticipated start date | 2023-08-15 | 2023-08-15 |
Actual start date | 2023-08-15 | 2023-08-15 |
Estimated end date | 2025-12-31 | Unknown |
Actual end date | ||
Shortage status | Actual shortage | Anticipated shortage |
Tier 3 Status | No | No |
Company comments | Peanut is contained under DIN 00299979, along with several other non-pollens allergenic extracts. In order to permanently discontinue the product, it cancels the DIN, which we do not want to do. Arpan Maheta (ALK) has been in contact with Shavini Karunaratne from DIN Issuance unit waiting for direction on how to proceed with discontinuing the product without cancelling the DIN. | |
Health Canada comments |